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Commissioned by President Dwight Eisenhower in 1958 and opened with a dedication
ceremony in December 1961, the USDA, Agricultural Research Service (ARS), National
Animal Disease Center (NADC) celebrated its 50-year anniversary in November 2011. Over
these 50 years, the NADC established itself among the world’s premier animal health
research centers. Its historic mission has been to conduct basic and applied research on
selected endemic diseases of economic importance to the U.S. livestock and poultry
industries. Research from NADC has impacted control or management efforts on nearly
every major animal disease in the United States since 1961. For example, diagnostic tests
and vaccines developed by NADC scientists to detect and prevent hog cholera were
integral in the ultimate eradication of this costly swine disease from the U.S. Most major
veterinary vaccines for critical diseases such as brucellosis and leptospirosis in cattle,
porcine respiratory and reproductive syndrome (PRRS), porcine parvovirus and inﬂuenza
in swine had their research origins or were developed and tested at the NADC. Additional
discoveries made by NADC scientists have also resulted in the development of a nutritional
approach and feed additives to prevent milk fever in transition dairy cattle. More recently,
NADC’s archive of historic swine inﬂuenza viruses combined with an established critical
mass of inﬂuenza research expertise enabled NADC researchers to lead an effective
national research response to the pandemic associated with the novel 2009 H1N1
inﬂuenza virus. This review commemorates some of the key animal health contributions
in NADC’s ﬁrst 50 years, recaps the newly completed modernization of the center into new
facilities, and offers highlights of the ongoing research that will deﬁne NADC’s mission
going forward.
Published by Elsevier B.V.
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1. Introduction
The National Animal Disease Center (NADC) was
established in Ames, Iowa in 1961, following a nation-wide
search and selection process to identify a suitable location.
Key factors that ultimately drove the selection of Ames for
the new USDA research center were its close proximity and
programmatic alignment with the Iowa State University
College of Veterinary Medicine, a central location within the
nation’s major livestock producing region, and availability of
an attractively-priced parcel of land suitable for constructing the new facility. At the time, the NADC represented the
state-of-the-art in design and construction of high-containment animal health research facilities. Indeed, the original
facilities served the center and the nation well in supporting
research on some of the most infectious livestock diseases of
the era. As a historical note of interest, these original
facilities were decommissioned in 2011 after NADC staff
moved into new state-of-the-art laboratories and administrative facilities at the same Ames location.
Since its inception, the NADC has combined a unique
blend of multi-disciplinary technical and scientiﬁc expertise
with state-of-the-art facilities and infrastructure to investigate the country’s most signiﬁcant animal health problems.
NADC researchers specialize in performing high-level
biocontainment research (BSL-2 and BSL-3 levels), involving
infectious and potentially zoonotic disease challenge
studies in cattle, swine, sheep and poultry. To respond to
a growing national concern that traditional zoonotic
diseases such as tuberculosis, brucellosis, or emerging
diseases such as chronic wasting disease can become
established in wildlife reservoirs and then re-emerge in
livestock or humans, NADC has established the scientiﬁc and
animal handling expertise to incorporate elk, bison, feral
swine, white-tailed deer and other cervids, and a range of
other species into routine disease pathogenesis, transmission and vaccinology research. Indeed, NADC’s new high
biocontainment facilities were designed with unique
penning and gating systems required to support infectious
disease research in these wildlife and livestock species.
Many of the infectious diseases of livestock that were
present back in 1961 remain as signiﬁcant disease threats
today (e.g. leptospirosis, brucellosis, Johne’s disease, and
others (Hartskeerl et al., 2011; Kennedy, 2011; Pappas,
2010). With global mobility of people and animals at
higher levels than ever before, the speed and potential for
both ‘historic’ and newly emerging infectious diseases to
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signiﬁcantly impact both animal and human health is everincreasing. Today, as throughout its history, the challenge
for NADC is to keep the country one step ahead of current
and emerging disease threats in livestock through research. This review will showcase research that enabled
NADC to meet this challenge during its ﬁrst 50 years, and
will highlight the capabilities of its modernized facilities,
which along with the strategic application of basic science,
promises to deﬁne its mission going forward.
2. Highlights of NADC’s ﬁrst 50 years
Initially named National Animal Disease Laboratory
(NADL), construction of the facilities began in 1958 in
Ames, Iowa (Fig. 1). All USDA animal health-related
research at that time was conducted at facilities in
Beltsville, Maryland, and it was a major undertaking to
move established animal colonies, dedicated to existing
research projects, to Ames. With these logistical obstacles
overcome, the ﬁrst scientiﬁc experiments began in 1961 at
the same time the ﬁrst director, William A. Hagen, was
hired. The new facilities were dedicated on June 27, 1961
and the diseases to be studied included hog cholera,
tuberculosis, brucellosis, vibriosis, mastitis, leptospirosis,
vesicular stomatitis virus, swine erysipelas and bovine
shipping fever. The ﬁrst two research articles stemming
from research conducted at the new NADL were published
by October of the same year, one reporting the presence of
Leptospira on a Pennsylvania farm (Clark et al., 1961) and
the second examining culture conditions for the swine
pathogen Erysipelothrix rhusiopathiae (White and Shuman,
1961). One particularly noteworthy achievement, among
several major research accomplishments from NADC’s
initial years, was the development of an economically
feasible and rapid diagnostic test that enabled eradication
of hog cholera and the concurrent establishment of NADC’s
world-class team of swine virology researchers.
3. Swine viral diseases caused by classical swine fever
virus, porcine parvovirus, hemagglutinating
encephalomyelitis virus and PRRS virus
In the 1800s and ﬁrst half of the 1900s, outbreaks of hog
cholera swept over the countryside, and the causative
agent, classical swine fever virus, was considered endemic
across the United States. Hog cholera caused losses that
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4. Integrating veterinary pathology and animal health
research
The close partnership between the Iowa State University
College of Veterinary Medicine and NADC has fostered the
professional development of numerous veterinary pathologists, and the integration of veterinary pathology into most
of NADC’s research programs. A number of NADC’s
scientists, including Drs. Lawrence H. Arp, Norman F.
Cheville, Randall C. Cutlip, Janice M. Miller, and Harley W.
Moon, have been board certiﬁed veterinary pathologists
who went on to make signiﬁcant contributions to the basic
understanding of pathophysiological mechanisms underlying various diseases. For example, Dr. Cheville is internationally known for his work in characterizing ultrastructural
changes in disease and for his seminal book on the topic
(Cheville, 2009). Dr. Arp’s greatest contributions were in
describing pathophysiology and lesions of various diseases
in turkeys. Dr. Cutlip made contributions in the areas of
transmissible spongiform encephalopathies (TSEs), adenovirus, pasturellosis, ovine progressive pneumonia, and other
respiratory pathogens. Contributions by Drs. Miller and
Moon are particularly noteworthy and are summarized in
the next two sections.
5. Discovery of bovine leukemia virus and
immunohistochmical detection of prion proteins
Fig. 1. NADC facilities located in Ames, Iowa when it ﬁrst opened in 1961
(A) and today (B).

devastated the hog farming industry at the time and still
cost swine producers $50 million a year by the 1960s (U.S.
Department of Agriculture, 1978). In 1963, NADC scientist
Dr. William Mengeling and coworkers developed a rapid
immunoﬂuorescent antibody test that took less than a day
to diagnose classical swine fever virus infection (Mengeling et al., 1963). No other economically feasible diagnostic
test was available at the time, and no equal or better test
has since been developed. This rapid test enabled one of
the greatest accomplishments in NADC’s history, the
eradication of hog cholera in the United States by 1978.
Dr. Mengeling (Fig. 2) and his colleagues later applied
their expertise in viral diseases of swine to make
signiﬁcant advancements in vaccine development for PRRS
(Mengeling et al., 1999a,b,c) and porcine parvovirus
(Mengeling et al., 1979; Paul and Mengeling, 1984,
1986). He was the ﬁrst to isolate porcine parvovirus
(Mengeling, 1972) and to deﬁnitively establish, under both
ﬁeld and laboratory conditions, its role in maternal
reproductive failure of swine. Prior to the availability of
an effective vaccine, porcine parvovirus-induced reproductive failure was estimated to cost the swine industry
between $25 and $75 million annually. A strain of porcine
parvovirus (NADL 2) isolated and characterized at NADC
was used to develop both inactivated and attenuated
vaccines for porcine parvovirus-induced reproductive
failure. All commercially available vaccines on the market
today contain the NADL 2 strain of virus, and their
production and testing was patterned after the procedures
described at the NADC. Millions of vaccine doses have been
distributed and used since it was ﬁrst licensed.

Dr. Janice M. Miller (Fig. 2) began her career at NADC in
1968 working as a pathologist on bovine leukemia virus
(BLV). She not only discovered BLV (Miller et al., 1969), but
also developed an antibody test, targeting a glycoprotein to
detect the virus (Miller and Van Der Maaten, 1977). During
her career, she also worked on bovine herpesvirus (Miller et
al., 1991), bovine immunodeﬁciency-like virus (Whetstone
et al., 1991), bovine tuberculosis (Miller et al., 2002), and
other major cattle diseases, greatly reducing their threat to
U.S. livestock production and exports. She ﬁnished her
career working in transmissible spongiform encephalopathies (TSEs) including transmissible mink encephalopathy
in cattle, chronic wasting disease in cervids and scrapie in
sheep. She developed immunohistochemical (IHC) techniques for detection of the prion protein in brain tissue of
sheep with scrapie (Miller et al., 1993). This IHC test was
subsequently applied globally to TSEs that affect other
animal species, and continues to serve as a deﬁnitive
diagnostic test for TSEs to this day. Dr. Miller (NADC’s ﬁrst
female veterinarian researcher) had a highly distinguished
career that culminated in her becoming a member of both
the US National Academy of Sciences and the ARS Hall of
Fame. However, despite her considerable professional
achievements, she would frequently and humbly quote,
‘‘I’m a jack of all trades, but master of none.’’
6. Enteropathogenic Escherichia coli infections in
animals
Dr. Harley Moon’s research team at the NADC examined
the interactions between diarrheagenic E. coli and animal
intestinal tissues at the molecular, cellular and tissue levels,
employing state-of-the-art technologies as they became

J.P. Bannantine et al. / Veterinary Microbiology 165 (2013) 224–233
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Fig. 2. NADC scientists in the ARS hall of fame. Clockwise from upper left: Ron Horst, William Mengeling, Harley Moon and Janice Miller.

available. His research and that of his collaborators identiﬁed
and characterized ﬁmbriae (pili) as speciﬁc and essential
virulence factors enabling enterotoxigenic E. coli to attach to
enterocytes in neonatal cattle, pigs, and lambs. Efﬁcacious
ﬁmbrial-based vaccines providing passive protection against
colibacillosis for neonatal farm animals evolved from this
research (Moon and Bunn, 1993), and remain a prime
example of a technology successfully transferred from
USDA-ARS laboratories to commercial production.
Dr. Moon (Fig. 2) published the ﬁrst detailed description
of enteropathogenic E. coli (EPEC) attachment to pig and
rabbit intestinal epithelial cells, an attachment associated
with exfoliation of epithelial cell microvilli (Moon et al.,
1983). He originated and popularized the term ‘‘attaching
and effacing’’ (AE) for the distinct appearance of this
colonization mechanism ﬁrst described by researchers at
Oklahoma State University (Staley et al., 1969). The
intestinal cells form pedestals or ‘cups’ into which the E.
coli bacteria nestle. The AE colonization mechanism is
typical of colonization of cattle intestines by strains of

E. coli which are foodborne pathogens of humans, e.g. E. coli
strain O157:H7. Dr. Moon’s foundational observations
opened new ﬁelds of research with a focus on molecular
pathogenesis, immunology, and genetics of AE E. coli and
new strategies for controlling E. coli foodborne infections
(Sharma et al., 2011).
Not only at the NADC, but around the world, Dr. Moon
was a role model veterinary scientist for several
generations of scientists investigating microbial-host
interactions in pathogenesis. With nearly 200 highly
cited publications, he remains one of the most productive researchers to have worked at the NADC. Dr. Moon
served as NADC’s fourth director from 1988 to 1995. He
was elected to the U.S. National Academy of Sciences in
1991 and inducted into the ARS Hall of Fame in 2000.
7. Metabolic disease: milk fever and vitamin D research
NADC’s research portfolio has historically consisted of a
balance between infectious and metabolic diseases. The
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most notable metabolic disease research investigated
metabolic diseases of cattle and was led by Drs. Ronald
Horst, Jesse Goff and Tim Reinhardt. This group is
renowned internationally for their work on milk fever
in dairy cattle and vitamin D metabolism. Milk fever
results from a metabolic imbalance of calcium that occurs
at the onset of calving and affects  6% of cows at a cost to
the dairy industry of $250 million annually. In milk fever
cases, the animal is unable to mobilize enough calcium
stores to compensate for losses through milk secretion
and thus becomes hypocalcemic and exhibits clinical
symptoms that include loss of appetite, lateral recumbency, tetany and eventual death if left untreated.
Secondary diseases are a common sequelae to milk fever
and include ketosis, displaced abomasum and mastitis. Dr.
Horst (Fig. 2) and co-workers’ research led to the
discovery that milk fever was caused by high levels of
dietary cations (K+, Na+, Ca2+, and Mg2+), which resulted in
a metabolic alkalosis that prevented the action of
parathyroid hormone in the periparturient cow. This lack
of parathyroid activity resulted in a loss of calcium
regulating mechanisms and a life-threatening drop in
blood calcium. These studies broke with conventional
veterinary textbook dogma at the time–that high dietary
calcium was the cause of milk fever. They found that the
simple addition of chloride ion to feed would alleviate this
metabolic alkalosis and overcome the blockade to
parathyroid function imposed by excessive dietary
potassium and thereby dramatically reduce the incidence
of milk fever (Goff and Horst, 1998). This research has
resulted in the commercialization of the product SoyChlor, a feed additive for dairy cattle that is still on the
market and remains effective against the condition.
Dr. Horst’s team also elucidated the processes of
activation and deactivation of fat-soluble vitamins,
especially vitamin D. Drs. Reinhardt and Horst developed
a quick and easy assay to measure 1,25-dihydroxyvitamin
D that remains NADC’s most cited article to date
(Reinhardt et al., 1984), and has also been applied to
vitamin D studies in human medicine to enhance the
understanding of renal failure, osteoporosis and neoplasia
(Koszewski et al., 1999; Salusky et al., 1990; Slatopolsky et
al., 1984). More recently, Drs. John Lippolis and Reinhardt
discovered that vitamin D profoundly affects innate
immune function in cattle and that when co-administered
with antibiotics into the mammary gland can augment
and enhance the efﬁcacy of antibiotics in treating chronic
mastitis (Lippolis et al., 2011; Nelson et al., 2010). Dr.
Horst authored or co-authored over 330 peer-reviewed
publications, the most of any NADC scientist. He received
the Presidential Rank Award of Meritorious Senior
Professional, and was inducted into the ARS Hall of Fame
in 2010.
8. Discovery and eradication of bovine leukocyte
adhesion deﬁciency
A team of scientists led by Dr. Marcus E. Kehrli, Jr., from
NADC made a serendipitous discovery that led to the
virtual elimination of an autosomal recessive lethal
condition in Holstein dairy cattle around the world

(Shuster et al., 1992b). This was the result of an
observation on a control calf in an unrelated experiment
in 1989 with a syndrome reminiscent of human leukocyte
adhesion deﬁciency. The occurrence of this condition led to
experiments describing the molecular nature of what was
later conﬁrmed to be a b2-integrin adhesion molecule
deﬁciency on bovine leukocytes (Kehrli et al., 1992, 1990).
This condition was deﬁned as bovine leukocyte adhesion
deﬁciency and the acronym BLAD was coined, which it is
now known throughout the dairy industry. Research
demonstrated this condition existed in U.S. Holstein cattle
since 1941 and was likely around long before that time.
Genetic testing is now routinely performed for this
condition around the world. Around the time of its
discovery, the prevalence of BLAD was slowly but steadily
increasing. In 1991, BLAD was estimated to account for
over 100,00 annual global calfhood deaths and its global
prevalence was steadily increasing. The NADC-led research
team deﬁned the molecular basis for the function of the
defective protein, and sequenced the normal and defective
bovine CD18 alleles in Holstein cattle (Shuster et al.,
1992a), and they developed a diagnostic PCR assay to
genotype cattle on the basis of their CD18 alleles. It was
immediately recognized that BLAD was carried by several
of the most prominent sires and cows of the HolsteinFriesian breed over the previous 50 years. However, as a
result of the patented diagnostic test, the number of young
bulls enrolled as artiﬁcial insemination bull studs and
carrying the defective allele causing BLAD has been
virtually zero since 1993. This research solved a major
but previously unrecognized problem of considerable
importance to dairy farmers and practitioners of veterinary
medicine throughout the world.
9. Innovation in laboratory biosafety/biosecurity
Novel safety innovations designed and built at NADC
include a ﬁnger pipetting device that eliminated the need
for mouth pipetting of harmful substances (Songer et al.,
1971), a portable ethylene oxide chamber used for
sterilizing heat-labile materials (Songer and Mathis,
1969), and an ultra ﬁlter for germ free animal isolation
units (Songer et al., 1978, 1974). Furthermore, NADC
scientists evaluated the effectiveness of standard safety
practices. For example, the effectiveness of decontaminating boots using various methods was ﬁrst assessed at
NADC (Braymen et al., 1974). This study found that
footbaths were an ineffective method at removing microorganisms on the surface of footwear. The results of this
study were later used by the shrimp farming industry to
stop the practice of footbaths (Moss, 2002), which may
actually foster the propagation of microorganisms. Also
extensive testing of harmful disinfectants such as formaldehyde and phenol was conducted and reported (Braymen
and Songer, 1971; Songer et al., 1972). These results were
used as guidelines for the decontamination of Bacillius
anthracis at the U.S. Post Ofﬁce in Landover, MD (Canter et
al., 2005). More recently, NADC facilities have hosted
several international biosafety conferences, including a
gathering of high-containment laboratory directors from
around the world.
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10. The Ames Modernization Project and NADC’s
current research
Plans to modernize and replace the NADC and USDA
APHIS animal health facilities co-located on the USDA Ames
campus were initiated in the mid-1990s. These modernization plans came to be known as the ‘USDA Ames
Modernization Project’ and ultimately represented the
largest construction project ever undertaken in USDA
history. The USDA Ames Modernization Project was strongly
supported by a broad-based coalition of animal production
and health stakeholders who successfully inﬂuenced
bipartisan Congressional and Presidential support to win
approval for funding totaling $467 M. Design of the new
facilities commenced in 2001 and construction was
completed in 2009. The newly constructed facilities are
among the most extensive and advanced high-containment
large animal disease research facilities in the world; there
are fewer than ﬁve comparable facilities worldwide. These
state of the art facilities combined with concurrent advances
in the scientiﬁc ﬁelds of genomics, microbial ecology,
immunology, and systems biology are converging to create
an unprecedented opportunity for NADC scientists to build
upon their strong tradition of leadership in animal health
research and continue to deﬁne innovation and global
leadership in animal health and food safety research.
Dr. Kurt Zuelke became NADC’s seventh Director in
2006. To coincide with the transition into the new facilities
in 2009, the NADC leadership team developed an ambitious ﬁve-year business plan that leveraged the new
facilities with ongoing scientiﬁc advances in genomics and
the life sciences to address the nation’s most pressing
animal health problems. NADC is now focused around four
strategic research themes that include ruminant diseases
and immunology; emerging diseases (most notably viral
and prion diseases); zoonotic diseases in wildlife and
livestock species; and, microbial ecology in food safety and
animal health. Although the core of animal health research
continues to revolve around basic disease pathogenesis
and transmission research, NADC researchers across all
four of these strategic themes are pioneering early
development and integration of high-throughput genomics and systems biology platforms to yield new and
exciting breakthroughs in molecular-based diagnostic and
disease intervention technologies.
11. Genomics and metagenomic studies of
agriculturally important species
NADC is at the forefront of genomics, functional
genomics and metagenomics research as it relates to
infectious diseases and foodborne diseases of animals.
Pasteurella multocida (May et al., 2001), Mycobacterium
avium subsp. paratuberculosis (Li et al., 2005) and Brucella
abortus (Halling et al., 2005) were among the ﬁrst animal
pathogens with genomes sequenced by researchers at
NADC along with their collaborators. Microarrays constructed from pathogen sequence data have been produced
using information from these genomes for transcriptomic
and genomic diversity studies (Boyce et al., 2002, 2004;
Marsh et al., 2006; Nicholson, 2007).
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NADC is leveraging next-generation sequencing technologies by investing in the latest equipment and training
researchers. With the rapidly developing power and lower
cost of these technologies, metagenomic studies have
become achievable. The ﬁrst analysis of the avian intestinal
metagenome in feed-deprived 3-week-old turkeys was
accomplished using molecular techniques (Scupham,
2007). Data revealed a high percentage of Papillibacter in
fasting turkeys, suggesting that these microbes may be
speciﬁcally dividing in response to the environmental
conditions.
Recently, NADC researchers and colleagues at Michigan
State University applied metagenomics and quantitative
PCR analyses to assess the impact of dietary antibiotics on
the swine intestinal microbiome (Looft et al., 2012). These
investigators demonstrated shifts in intestinal microbial
populations, including elevated E. coli shedding, and
increases in various metabolic and antibiotic resistance
genes. The detection of bacteriophage carrying antibiotic
resistance genes and likely capable of spreading the genes
was also a discovery from these studies (Allen et al., 2011).
Understanding the effects of antibiotics on intestinal
microbes enhances our ability to monitor antibiotic use
and discover antibiotic alternatives.
12. Animal health research response to the 2009 H1N1
inﬂuenza A virus outbreak
In early 2009, a novel pandemic H1N1 inﬂuenzae A
virus (H1N1pdm09) emerged in the human population in
North America. This antigenically distinct H1N1 quickly
spread in the human population, and the World Health
Organization declared on June 11, 2009, that the outbreak
had reached pandemic phase 6. Although the sequences of
the virus’s eight gene segments were similar to those of
corresponding genes from swine inﬂuenza A viruses from
North America and Eurasia, no closely related ancestral
inﬂuenza A viruses with this gene combination had been
previously identiﬁed anywhere in the world. For the
human population, the genome of the H1N1pdm09 virus
contained novel forms of the matrix (M) and neuraminidase (N1) genes that rendered this virus antigenically
distinct from previously circulating strains (Garten et al.,
2009). Therefore, the global human and swine populations
were potentially immunologically naı̈ve to this virus, and
diagnostic tests available at the time could not differentiate it from other inﬂuenza virus strains. Within the ﬁrst
few weeks of the 2009 pandemic, a team of NADC scientists
led by Drs. Amy Vincent, Kelly Lager and Kay Faaberg
developed a differential diagnostic test for the pandemic
virus in swine and conducted a series of high containment
pathogenesis, transmission, and vaccine experiments with
the H1N1 virus in swine (Vincent et al., 2010, 2009).
In response to this outbreak, a number of key countries
immediately closed their borders to U.S. pork exports
citing potential concerns that the H1N1 virus could affect
the safety of U.S. pork products. The pathogenesis studies
performed at NADC were the ﬁrst to demonstrate that the
tissue distribution of the 2009 pandemic virus was limited
to tissues of the respiratory tract and that the virus was
quickly cleared from infected pigs. These results conﬁrmed
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that the H1N1 virus did not pose a food safety risk (Vincent
et al., 2009) and that U.S. pork products were safe. This
rapid research response enabled science-based decisions
on the safety of U.S. pork and pork products during the
early stages of the pandemic by providing data that was
invaluable to U.S. and international pork producers. The
U.S. government and the U.S. pork industry cited this
research while engaging trading partners in a sciencebased conversation to maintain and re-open market access
to over 27 countries that had banned or threatened to ban
U.S. pork and pork products, costing the industry over
$5.0 M per day.
13. Foodborne pathogens
In response to the needs of producers and consumers, a
major research paradigm shift occurred at the NADC in the
late 1990s. Investigators who previously focused on
controlling enteric bacterial pathogens of farm animals (E.
coli, Salmonella, and Brachyspira hyodysenteriae), adopted
food safety research projects. They form the nucleus of the
current Food Safety and Enteric Pathogens (FSEP) Unit. The
FSEP Unit aims to reduce numbers of human foodborne
pathogens and antibiotic resistant microbes in animals on
the farm, before they get to humans. New chemical,
biological, genetic, and immunological strategies are being
explored, not only as control measures for human foodborne
pathogens (and animal pathogens), but also as alternatives
for reducing antibiotic use.
An early food safety intervention, from the labs of Drs.
Tom Casey, Mark Rasmussen, and Iowa State University
collaborator, Jacob Petrich, was the invention of a ﬂuorescence detector for real time monitoring of animal carcasses
for fecal contamination, a most important source of
foodborne pathogens in meat products (Ashby et al.,
2003). For this invention, these researchers were recognized
by a national R&D 100 award for a top 100 invention of the
year, a ‘da Vinci’ Award from the State of Iowa, and a Superior
Service Honor Award from the U.S. Secretary of Agriculture.
14. Antibiotic resistance
An important concern in animal agriculture today is the
widespread use of antibiotics in animal feed. The extent of
antibiotic resistance among members of the microbiome of
animals has only begun to be appreciated in recent years;
this results in clinical issues pertaining to treatment of
animal diseases caused by resistant bacteria. Furthermore,
it generates concern over the spread of antibiotic resistant
bacteria, especially foodborne pathogens from animals to
humans. But mechanistically, how does resistance to
antibiotics spread? Studies at NADC have recently shown
that antibiotic resistance genes are present in bacteriophage from swine fecal samples (Allen et al., 2011). These
authors further demonstrate that the presence of antibiotics in animal feed induces latent phages to activate a
lytic infection providing a means for antibiotic resistance
gene transfer.
Selective pressure from frequent antibiotic use can
drive both the spread and the evolution of antibiotic
resistance genes. Dr. Arthur Andersen and collaborator Dr.

Dan Rockey were the ﬁrst to demonstrate the presence of
tetracycline resistance in swine strains of Chlamydia suis
(Dugan et al., 2007, 2004; Lenart et al., 2001) and how
readily new resistance is acquired through horizontal
transfer and recombination events (Suchland et al., 2009).
They showed the mosaic recombination of intraclass
tetracycline resistance genes, which suggests the ease of
transfer and intermingling of tet(C) alleles. Although the
presence of antibiotic resistant chlamydia was initially
controversial, tetracycline resistant strains are now widely
accepted in the chlamydial ﬁeld. NADC scientists also
discovered the ﬁrst example of interclass genetic recombination of tetracycline resistance genes, tet(O) and tet(W)
alleles, in the strict anaerobe Megasphera elsdensii, a nonpathogen commensal bacterium, from the swine gut
(Stanton et al., 2011).
15. Conclusion and future perspectives
While this review has focused on a select few highlights, in total NADC scientists have collectively published
over 3000 research articles since the center opened in
1961. A selection of additional noteworthy accomplishments are listed in Table 1. Today, the national need for
innovative high impact animal health and food safety
research at NADC and elsewhere has never been greater. Of
the 1415 species of infectious organisms known to be
pathogenic in humans, 61% are zoonotic, and more
strikingly, 75% of newly emerging human pathogens are
zoonotic (Taylor et al., 2001). The recent 2009 H1N1
pandemic inﬂuenza outbreak illustrates just how quickly a
zoonotic infection can emerge and spread globally. With
the global population estimated to grow to over 9 billion
people by 2050 (Lee, 2011), there will continue to be an
ever-increasing demand for new technologies to produce
more food more efﬁciently while assuring food safety.
Research solutions that enable cost-effective production of
healthy livestock and poultry will be a critical component
in a comprehensive strategy to assure global food security
to meet the nutritional needs of the future population base.
As future population pressures on the environment
increase, the resulting loss of habitat will lead to closer
proximity of wildlife and livestock populations and
increase the likelihood of disease transmission among
these animal populations and perhaps between animals
and humans. Continued research using a combination of
wildlife and domestic livestock animal models will be
crucial to mitigating the potential impact of wildlife
reservoirs of zoonotic diseases to human and animal
health. The NADC research community is proud of the
pioneering efforts of their scientists to date. Building upon
the foundation laid down during the past 50 years with
newly constructed facilities and cutting edge technologies,
the NADC is well-positioned to lead the nation to meet the
current and upcoming animal health and food safety
challenges in the years to come.
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Table 1
Additional signiﬁcant research accomplishments at NADC.
Disease/disease agent/
research target

Contribution

Researchers

Year(s) reported

Bovine viral diarrhea virus

Isolation of a strain of this virus later recognized
as the type strain of BVDV1. Is a component of
numerous vaccines.

DE Gutekunst, WA Malmquist

1963

Leptospirosis

Developed culture medium for the isolation and
propagation of leptospira bacteria.

HC Ellinghausen Jr, WG
McCullough

1965

Pink eye/Moraxella bovis

Identiﬁcation of Moraxella bovis as a cause of
‘‘pink eye’’ in cattle.

DE Hughes, GW Pugh Jr,
TJ McDonald

1965–1968

Johne’s disease/Mycobacterium
avium subsp. paratuberculosis

Developed fecal culture techniques for early
detection of these slow growing mycobacteria.

RS Merkal, AB Larsen

1962–1964

Newcastle disease virus

Development of a killed vaccine against the
Newcastle disease virus

HD Stone, AE Richies, WA
Boney

1969

Bovine leukemia virus (BLV)

Demonstration that bovine leukemia is caused
by a virus.

JM Miller, C Olson

1972

Bovine leukemia virus (BLV)

BLV ﬁrst cultivated.

MJ Van der Maaten, JM Miller

1974

Fowl cholera/Pasteurella multocida

An improved bacterin developed that provided
70% cross protection from other strains of
Pasteurella.

KA Brogden, KR Rhoades,
KL Heddleston

1978

Oxalate metabolism/Oxalobacter
formingenes

Demonstration of importance of microbial
metabolism of oxalate in animal & human
health

MJ Allison, KA Dawson, NA
Cornick, AL Baetz

1980–1990, 1996

Salmonella typhimurium
infection of swine

Identiﬁed the prefered colonization sites in
swine that are persistently infected with
Salmonella typhimurium.

RL Wood

1989

Feline calicivirus

First nucleotide sequence of calicivirus
30 -terminal sub genomic RNA.

JD Neill

1991

Brucellosis/Brucella abortus

Demonstrated that vaccination of bison with
the RB51 strain induced abortion.

SC Olsen, MV Palmer

1996

Swine dysentery/Brachyspira
hyodysenteriae

Discovery and genetic engineering application
of novel gene transfer mechanism (VSH-1)

TB Stanton, SB Humphrey

1997–2008

Bovine viral diarrhea virus and
border disease virus

First nucleotide sequence of bovine diarrhea
virus 2 strain and border disease virus

JF Ridpath, SR Bolin

1995, 1997

Brucellosis/Brucella abortus

Approval of RB51 for use in cattle for prevention
of Brucella abortus infection

NF Cheville, SC Olsen, MV
Palmer

1997

Shipping fever

First genetically engineered live oral vaccine for
shipping fever.

RE Briggs, FM Tatum

1999

Bovine tuberculosis/
Mycobacterium bovis

Intratonsilar challenge model developed to
mimic natural M. bovis infection in white-tailed
deer.

MV Palmer, DL Whipple, WR
Waters

2000

Preharvest food safety

Developed a fecal contamination detector for
animal carcasses using light sources of different
wavelengths

TA Casey, MA Rasmussen

2003

Bovine tuberculosis/
Mycobacterium bovis

A calf aerosol challenge model developed for M.
boivs

MV Palmer, WR Waters

2003

Johne’s disease/Mycobacterium
avium subsp. paratuberculosis

Demonstrated that milk pasteurization
effectively kills Mycobacterium avium
subsp. paratuberculosis

JR Stabel

2004

Scrapie, Chronic wasting disease
(CWD) and transmissible mink
encephalopathy

First to complete interspecies transmission
studies into cattle. Found that cattle were
resistant to scrapie and CWD.

AN Hamir, RA Kunkle, JA Richt,
JM Miller, RC Cutlip

2007
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Table 1 (Continued )
Disease/disease agent/
research target

Contribution

Researchers

Year(s) reported

BSE/Prion

Conﬁrmed that the E211 K polymorphism
discovered at NADC in 2008 was a germline
polymorphism indicating certain rare, atypical
BSE cases may be heritable.

EM Nicholson, BW Brunelle, JA
Richt, ME Kehrli, JJ Greenlee

2008

Adenovirus

Developed PCR assay to classify ruminant
adenovirus to determine serotype/species.

HD Lehmkuhl, LA Hobbs

2008

Bovine tuberculosis/
Mycobacterium bovis

Developed a rapid serologic test for cervids that
USAHA recommended using in the TB
erradication program.

WR Waters, MV Palmer

2011

Johne’s disease/Mycobacterium
avium subsp. paratuberculosis

Isolation of the ﬁrst M. avium subspecies
paratuberculosis-speciﬁc monoclonal antibody.

JP Bannantine, JR Stabel

2011

and administrative support staff who have devoted their
careers to ARS and the NADC. We also thank Janis K. Hansen
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not imply recommendation or endorsement by the U.S.
Department of Agriculture. USDA is an equal opportunity
provider and employer.
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